Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Robert Matthew Kottman"'
Autor:
Aleksandr Kalininskiy, Ashley Rose Rackow, David Nagel, Daniel Croft, Heather McGrane-Minton, Robert Matthew Kottmann
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Rationale Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease that has no cure. Many current research efforts center on diagnostic and therapeutic modalities for IPF while other risk factors affecting dise
Externí odkaz:
https://doaj.org/article/0a8f4994246549e1a84a27ff523723f7
Autor:
Joshua J. Mooney, Daniel A. Culver, Sachin Chaudhary, Murali Ramaswamy, Gregory P. Cosgrove, Alpa G. Desai, Sonye K. Danoff, Amy Case, Stephen Weight, Rodeo Abrencillo, Joseph D. Zibrak, Srihari Veeraraghavan, Barry S. Shea, Nitin Y. Bhatt, Maryl Kreider, Doug Moore, Mary Beth Scholand, Shelley L. Schmidt, Thomas H. Schaumberg, Christopher S. King, Borna Mehrad, Justin M. Oldham, Bridget A. Graney, Adrian Shifren, Christophe He, Nathan Sandbo, Nishant Gupta, Michael Marll, Daniel F. Dilling, Tracy Luckhardt, Mridu Gulati, Tristan J. Huie, Craig S. Glazer, Nevins W. Todd, Peter Lacamera, Hyun Koo Kim, Mohamed Saad, Pauline Bianchi, James R. McCormick, Mark Hamblin, Yolanda N. Mageto, Robert Matthew Kottman, Teng Moua, Anna J. Podolanczuk, Scott Matson, Divya Patel, David Roe, Mary E. Strek, Lisa Lancaster, Krishna Thavarajah, Paul J. Wolters, Joyce S. Lee, Sydney B. Montesi, Rafael L. Perez, Rebecca Bascom, Nabeel Hamzeh, Tessy K. Paul, Anoop M. Nambiar, Prema Menon
Publikováno v:
Chest. 159:1517-1530
Background Management of patients with interstitial lung disease (ILD) requires subspecialized, comprehensive, multidisciplinary care. The Pulmonary Fibrosis Foundation established the Care Center Network (CCN) in 2013 with identified criteria to bec
Autor:
David J. Nagel, Ashley R. Rackow, Wei-Yao Ku, Tyler J. Bell, Patricia J. Sime, Robert Matthew Kottmann
Publikováno v:
Cells, Vol 11, Iss 16, p 2540 (2022)
Idiopathic pulmonary fibrosis (IPF) is a disease characterized by irreversible lung scarring. The pathophysiology is not fully understood, but the working hypothesis postulates that a combination of epithelial injury and myofibroblast differentiation
Externí odkaz:
https://doaj.org/article/3e6e3950c7e34610a09513be7ac00a77
Autor:
Ajit A Kulkarni, Thomas H Thatcher, Hsi-Min Hsiao, Keith C Olsen, Robert Matthew Kottmann, Jason Morrissette, Terry W Wright, Richard P Phipps, Patricia J Sime
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63798 (2013)
Pulmonary Fibrosis (PF) is a devastating progressive disease in which normal lung structure and function is compromised by scarring. Lung fibrosis can be caused by thoracic radiation, injury from chemotherapy and systemic diseases such as rheumatoid
Externí odkaz:
https://doaj.org/article/cc467949afda4006b9c5ce9d4bc6a25b